drugset / Trial / NCT03928379
A Study of LY3305677 in Participants With Type 2 Diabetes
RandomizedSequentialDouble-blindBasic science
Summary
The main purpose of this study is to learn more about the safety and side effects of LY3305677 when it is given as an injection just under the skin to participants with type 2 diabetes. The study will last about 20 weeks for each participant, not including screening.
Timeline
- Start
- 2019-10-27
- Primary completion
- 2021-07-08
- Completion
- 2021-07-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Mazdutide | Protein / enzyme biologic | — | Subcutaneous |